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Bobby R. Scott   Senior Scientist, Lovelace Respiratory Research Institute,
Albuquerque, NM
Ionizing radiation protection regulations for humans are based on
the presumption that any amount or radiation, no matter how small, will
cause cancer in a very large population. The regulations impact on the
use of ionizing radiation in routine diagnostic procedures (e.g., comput-
ed tomography), on allowable radiation levels in the environment (e.g.,
residential radon levels), and on allowable radiation exposures in the
workplace (e.g., nuclear facilities). Cancer risks evaluations are based on
the linear-no-threshold (LNT) paradigm for which risk is assumed to
increase linearly as the radiation dose increases (Puskin 2009).
Organizations such as the U.S. Environmental Protection Agency, the
National Council on Radiation Protection and Measurements, and the
International Commission on Radiological Protection rely on the LNT
risk model for establishing limits for human exposure to radiation. Indeed,
dose units such as millisievert (mSv), which apply to all forms of ionizing radia-
tion and their combinations, depend on the LNT hypothesis for their justifiable use. 
Justification for the continued use of the LNT risk model is based
largely on results from epidemiological studies that employ inappropriate
methods (Scott et al. 2008) such as the following: (1) giving considerable
weight to high-dose, high-dose-rate data where excess cancers clearly
occur while ignoring the absence of excess cancers after low doses and
dose rates; (2) dose lagging (i.e., discarding some of the dose thereby
shifting the dose-response curve to the left, making smaller doses appear
more harmful than they actually are); (3) attributing observed low-dose-
associated reductions in the cancer incidence among radiation workers to
a presumed healthy worker effect; (4) not allowing for the possibility that
a threshold or a reduction in risk at low doses may occur because of radi-
ation-stimulated adaptive protection; and (5) averaging over wide dose
intervals so that nonlinearity is removed.
This issue provides additional support for the rapidly growing view
that the LNT risk model should not be used for low-dose cancer risk
assessment. The paper by Fornalski and Dobrzyn´ski (2010) discusses the
inappropriate use of the healthy worker effect assumption in attempts to
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explain away actual cancer suppressive effects of low-dose radiation.
Jaworowski (2010) in his paper makes a clear presentation of how LNT-
related radiation phobia after the Chernobyl accident has caused signifi-
cant human suffering and unnecessary very large costs to Eastern
European populations impacted by the accident. He points out that
unlike the thousands of hypothetical late cancer deaths projected by
some (which did not occur) based on the LNT model, a 15% to 30%
deficit (relative to the general population) of solid cancer mortality was
found among the Russian emergency workers at Chernobyl and a 5%
deficit of solid cancer incidence among the population of the most con-
taminated areas. The paper by Vaiserman (2010) reviews some of the
abundant epidemiological and other data on radiation hormesis as it
relates to cancer suppression.
Mitchel (2010) points out in his paper that radiation adaptive
responses occur in all organisms and describes a dose window (which cor-
responds to the hormetic zone) over which cancer suppression via stimu-
lated adaptive protection occurs. The hormetic zone is thought to
depend on the type of radiation (Scott 2005; Elmore et al. 2009) and how
the radiation is delivered (e.g., brief high rate vs. protracted low rate
exposure [Elmore et al. 2006; Feinendegen et al. 2010]). The hormetic
zone is more pronounced for sparsely ionizing forms of radiation (e.g., x-
rays and gamma rays) than for highly ionizing forms (Scott 2005). The
sparsely ionizing forms are sometimes also in combination with highly
ionizing alpha radiation (e.g., as for residential radon) in which case a
hormetic zone may also be evident at low doses and dose rates if data are
properly analyzed (Thompson et al. 2008). 
The paper by Nowosielska et al. (2010) presents evidence from animal
studies of low-dose radiation stimulating antineoplastic immune surveil-
lance. The stimulated immunity can protect against cancer and metas-
tases and raises the possibility for use of low doses of radiation in pre-
venting cancers in high risk populations (e.g., long-time heavy smokers)
and curing early stage cancers (Scott and Di Palma 2006). 
Feinendegen et al. (2010) review the current state of knowledge about
radiation-stimulated adaptive protection against cancer and present a
Dual-Probability Model of cancer induction that allows for multiple levels
of protection (including metabolic-dynamic defenses) and for a hormet-
ic zone. The model integrates biological responses to irradiation over
multiples scales (molecular, cellular, and tissue levels). Based on analyses
conducted, the authors conclude that adaptive protection (radiation
hormesis) preventing only 2 – 3 % of endogenous life-time cancer risk
would fully balance a calculated (based on LNT) induced cancer risk at
about 100 mSv, in agreement with epidemiological data. 
Collectively, the papers in this issue indicate that low-dose radiation-
stimulated adaptive protection can no longer be justifiably ignored when
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evaluating risks from exposure to low radiation doses. This includes risks
from diagnostic procedures such as computed tomography that employ
radiation.
I was asked by Edward (Ed) Calabrese (2009 Marie Curie Prize recip-
ient) to serve as Guest Editor for this issue of the journal and was happy
to do so. It was a pleasure working with the contributing authors. All of
the invited authors readily volunteered to contribute papers. On behalf
of all the authors I would like to express our gratitude to Denise Leonard
(Managing Editor) for her help in preparing this special issue and to Ed
for supporting its publication. It is hoped that the issue will stimulate
interesting discussions world-wide as well as help foster new research
related to the use of low doses of sparsely ionizing radiation to prevent
and cure cancer and thereby lengthen life.
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